Research Article | Open Access
Yuanyuan Ying, Fei Wu, Chongyang Wu, Yi Jiang, Min Yin, Wangxiao Zhou, Xinyi Zhu, Cong Cheng, Licheng Zhu, Kewei Li, Junwan Lu, Teng Xu, Qiyu Bao, "Florfenicol Resistance in Enterobacteriaceae and Whole-Genome Sequence Analysis of Florfenicol-Resistant Leclercia adecarboxylata Strain R25", International Journal of Genomics, vol. 2019, Article ID 9828504, 10 pages, 2019. https://doi.org/10.1155/2019/9828504
Florfenicol Resistance in Enterobacteriaceae and Whole-Genome Sequence Analysis of Florfenicol-Resistant Leclercia adecarboxylata Strain R25
Due to inappropriate use, florfenicol resistance is becoming increasingly serious among animal respiratory tract and gut bacteria. To detect the florfenicol resistance mechanism among Enterobacteriaceae bacteria, 292 isolates from animal feces were examined. The agar dilution method was conducted to determine the minimum inhibitory concentration (MIC) for florfenicol, and polymerase chain reaction (PCR) was performed to detect florfenicol resistance genes. To further explore the molecular mechanism of florfenicol resistance, the whole-genome Leclercia adecarboxylata R25 was sequenced. Of the strains tested, 61.6% (180/292) were resistant to florfenicol, 64.4% (188/292) were positive for floR, and 1.0% (3/292) for cfr. The whole-genome sequence analysis of L. adecarboxylata R25 revealed that the floR gene is carried by a transposon and located on a plasmid (pLA-64). Seven other resistance genes are also encoded on pLA-64, all of which were found to be related to mobile genetic elements. The sequences sharing the greatest similarities to pLA-64 are the plasmids p02085-tetA of Citrobacter freundii and p234 and p388, both from Enterobacter cloacae. The resistance gene-related mobile genetic elements also share homologous sequences from different species or genera of bacteria. These findings indicate that floR mainly contributes to the high rate of florfenicol resistance among Enterobacteriaceae. The resistance gene-related mobile genetic elements encoded by pLA-64 may be transferred among bacteria of different species or genera, resulting in resistance dissemination.
Enterobacteriaceae bacteria are important species that comprise the gut microbiota of domestic animals. There are reports that members of this family cause infections, for example, Salmonella Gallinarum as the cause of septicemia in fowl typhoid, Escherichia coli causing severe respiratory diseases in poultry and bovine mastitis, and septicemia in pigs due to Klebsiella pneumoniae. Overall, the uncontrolled use of antibiotics for the treatment and prevention of infectious diseases in animals as well as their application as growth promoters in animal husbandry has contributed to the increased spread of antimicrobial resistance genes among Enterobacteriaceae bacteria, resulting in significant economic losses .
Florfenicol, a synthetic broad-spectrum antibiotic derived from chloramphenicol but with better antibacterial activity and few adverse effects, has been universally used in veterinary medicine [2, 3]. However, due to inappropriate use to prevent or cure bacterial infections, florfenicol resistance has become increasingly serious and a variety of florfenicol resistance mechanisms have been characterized, including efflux pumps, rRNA methyltransferases, and chloramphenicol acetate esterases. To date, seven florfenicol resistance genes, floR, cfr, fexA, fexB, pexA, optrA, and estDL136 [3–6], together with some variants (floRv, floSt, cfr(B), and cfr(C)) [7–9] have been discovered. Nonetheless, only a limited number of studies have reported the resistance to florfenicol or distribution of florfenicol resistance genes among Enterobacteriaceae, mainly including common species such as Escherichia coli, K. pneumoniae, Salmonella enterica, Yersinia enterocolitica, and Proteus vulgaris [10–14]. Moreover, the florfenicol resistance mechanisms of most Enterobacteriaceae species have not been investigated.
The genus Leclercia of the family Enterobacteriaceae contains only one species, L. adecarboxylata, which is a characteristic of a gram-negative, motile, and facultative anaerobic bacillus. First described as Escherichia adecarboxylata by Leclerc in 1962 , the species was renamed L. adecarboxylata by Tamura et al. in 1986 according to the recognition of its phenotypic and genotypic differences from species of the genus Escherichia and other species of Enterobacteriaceae . L. adecarboxylata, which is normally present in environmental or animal sources , is an opportunistic human pathogen but is rarely isolated from clinical specimens. Nonetheless, it has been reported to cause bacteremia, sepsis, peritonitis, cellulitis, endocarditis, and cholecystitis in immunocompromised patients with polymicrobial infections . There is no report thus far of a florfenicol molecular resistance mechanism of L. adecarboxylata isolated from an animal or the environment. In this work, we analyzed florfenicol resistance and the resistance genes of animal-derived Enterobacteriaceae bacteria and further examined L. adecarboxylata strain R25 to demonstrate the molecular resistance mechanism against florfenicol of this unique Enterobacteriaceae species.
2. Materials and Methods
2.1. Bacterial Strain and PCR Detection of Florfenicol Resistance-Associated Genes
Enterobacteriaceae strains were isolated from anal fecal samples obtained on food animal-producing farms (ducks, chickens, cows, geese, and rabbits) in Wenzhou, Zhejiang Province, China, from July 2014 to November 2015. A total of 292 Enterobacteriaceae strains were isolated. Species identification was conducted using a bioMérieux VITEK® 2 Compact Instrument (bioMérieux, Marcy L’etoile, France) and comparative analysis of 16S rRNA gene sequences from bacteria of the same genera in the National Center for Biotechnology Information (NCBI) database (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Further verification of L. adecarboxylata R25 was conducted by homologous comparisons of the whole-genome sequences with those in NCBI. The bacterial strains and plasmids used in this study are listed in Table 1.
Abbreviations: Amp: ampicillin; r: resistance.
Bacterial genomic DNA was extracted using an AxyPrep Bacterial Genomic DNA Miniprep Kit (Axygen Scientific, Union City, CA, USA) and used as the template for subsequent PCR. PCR amplification was conducted to screen florfenicol resistance genes floR, cfr, pexA, fexA, fexB, and estDL136. Primers were designed by using Primer Premier 5.0 (Table 2). The PCR products were further confirmed by Sanger sequencing (ABI 3730 Analyzer, Foster City, CA, USA). Both strands of the PCR products were sequenced with the forward and reverse primers, and the sequencing reads were assembled with the Phred/Phrap/Consed software package (http://www.phrap.org/phredphrapconsed.html). The sequence data were compared to the NCBI nucleotide sequence database using BLAST with the max target sequences of 100, expect threshold of 10, word size of 28, max matches in a query range of 0, match scores of 1, and mismatch scores of -2 (https://blast.ncbi.nlm.nih.gov).
2.2. Antibiotic Susceptibility Assay
The MICs of antimicrobial agents against the 292 Enterobacteriaceae strains and corresponding recombinants carrying cloned resistance genes were determined using the standard agar dilution method recommended by the Clinical and Laboratory Standards Institute (CLSI document M100-S27, 2017). A bacterial suspension was adjusted to a turbidity equivalent to a 0.5 McFarland standard with sterilized saline solution (0.9%) and plated on Mueller-Hinton agar containing different concentrations of various antimicrobial agents. The plates were incubated at 37°C for 24 h. The MIC was recognized as the lowest antibiotic concentration resulting in no colony growth. Each of the tests was carried out in triplicate. E. coli ATCC 25922 was used as a quality control strain. The resistance breakpoints of Enterobacteriaceae for florfenicol were set referring to those for chloramphenicol in the guidelines of CLSI document M100-S27 (2017).
2.3. Whole-Genome Sequencing
A 20 kb library was generated using a SMRTbell Template Prep Kit (Pacific Biosciences, Menlo Park, CA, United States) according to the PacBio standard protocol and sequenced using a PacBio RS II instrument. In addition, an Illumina library with 300 bp insert sizes was constructed and sequenced from both ends using the HiSeq 2500 platform (both PacBio RS II and HiSeq 2500 sequencing were carried out at Annoroad Gene Technology Co. Ltd., Beijing, China). Reads of the clean data derived from the raw data of HiSeq 2500 sequencing were initially assembled de novo with the SOAPdenovo software to obtain contigs of the genome sequences. PacBio long reads were assembled using Canu software . Two FASTQ sequence files corresponding to the reads derived from HiSeq 2500 sequencing were used to control assembly quality and to correct possibly misidentified bases. Potential ORFs were predicted using Glimmer software (http://ccb.jhu.edu/software.shtml) and annotated against a nonredundant protein database using BLASTX (https://blast.ncbi.nlm.nih.gov). Plasmid typing was performed using BLAST in the PlasmidFinder database (https://cge.cbs.dtu.dk/services/MLST/).
2.4. Cloning of Resistance Genes
The primers used to clone candidate genes with potential upstream promoter regions are shown in Table 2. PrimeSTAR HS DNA Polymerase (TaKaRa, Dalian, China) was used to amplify resistance genes according to the manufacturer’s instructions. A poly(A) tail was added to each purified PCR product (prom-ORF) using the DNA A-Tailing Kit (TaKaRa, Dalian, China), and the fragment was then cloned into the pMD™19-T vector (TaKaRa, Dalian, China). The resulting recombinant plasmid (pMD™19-T-prom-ORF) was transformed into E. coli DH5α using the calcium chloride method. Transformants were selected on LB agar plates containing 100 μg/mL ampicillin. The cloned PCR product was further confirmed by Sanger sequencing.
2.5. Comparative Genomic Analysis
The plasmid and chromosome genome sequences used in this study were downloaded from NCBI (http://www.ncbi.nlm.nih.gov). Comparisons of nucleotide and amino acid sequences were performed using BLASTN and BLASTP, respectively. The map of the plasmid with GC content and GC skew was drawn using the online CGView Server (http://stothard.afns.ualberta.ca/cgview_server/) and local GView 1.7 with visual interface . Family classification and domain prediction of mobile genetic elements (MGEs) were verified by comparison using the InterPro database (http://www.ebi.ac.uk/interpro/) and ISfinder database (https://isfinder.biotoul.fr/). Other bioinformatics tools were utilized through Perl and BioPerl (http://www.perl.org/).
3. Results and Discussion
3.1. Animal Enterobacteriaceae Bacteria and Their Resistance to Phenicols
Florfenicol as well as tetracyclines, beta-lactams, and trimethoprim/sulfonamides is widely used to treat animal infections. The resistance rates for these antibiotics have increased greatly, and the emergence of multidrug-resistant bacteria is increasing . In this work, we detected resistance to florfenicol and chloramphenicol among 292 Enterobacteriaceae strains isolated from fecal specimens of 5 types of animals (rabbit, chicken, cow, goose, and duck). The strains isolated belong to 11 genera: Escherichia (86.0%, 251/292), Shigella (0.7%, 2/292), Klebsiella (2.7%, 8/292), Serratia (0.3%, 1/292), Proteus (3.1%, 9/292), Citrobacter (1.7%, 5/292), Enterobacter (3.4%, 10/292), Yersinia (0.3%, 1/292), Leclercia (0.3%, 1/292), Pantoea (1.0%, 3/292), and Kluyvera (0.3%, 1/292) (Table S1). The overall resistance rates to florfenicol and chloramphenicol were 61.6% and 65.1%, respectively. Except for the 10 strains of Enterobacter, which exhibited low resistance rates of 20.0% to both florfenicol and chloramphenicol, all the other strains from various genera showed high resistance rates of 50.0-88.9% to florfenicol and 64.1-100.0% to chloramphenicol. Proteus spp. exhibited the highest resistance rate of 88.9% (8/9) to florfenicol; Klebsiella spp. and Escherichia spp. also displayed high resistance rates of 75.0% (6/8) and 62.5% (157/251) to florfenicol, respectively (Table 3).
Abbreviations: S: sensitive; I: intermediate; R: resistance. aCriteria as published by CLSI 2017. bUsing chloramphenicol breakpoints. cOther genera of Enterobacteriaceae bacteria including 2 Shigella, 1 Serratia, 5 Citrobacter, 1 Yersinia, 1 Leclercia, 3 Pantoea, and 1 Kluyvera.
The rates of resistance to florfenicol among the Enterobacteriaceae bacteria isolated in this work appeared to be much higher than those reported for bacteria from the same or different genera or families. For example, in one study, isolates of Pasteurella multocida, Actinobacillus pleuropneumoniae, and Streptococcus suis from cattle and pig respiratory tract infections showed resistance rates to florfenicol of <1% . Another report demonstrated that the rates of florfenicol resistance of A. pleuropneumoniae and P. multocida isolated from pig respiratory tract infections were 2.0% and 6.0%, respectively . Resistance rates of 25.4% and 15.3% to florfenicol have also been reported for Salmonella and Yersinia, respectively [13, 23]. In addition, E. coli strains from canine urinary tract infections showed higher resistance, at a rate of 31.6% (36/114), to florfenicol than did other pathogens . More recently, a resistance level to chloramphenicol for Staphylococcus pseudintermedius of 32 μg/mL (MIC90) was reported, but no resistance to florfenicol was detected in this species () . Despite these publications, there is no report thus far regarding the resistance to florfenicol for other species of Enterobacteriaceae. In this work, except for four genera with only 1 (Yersinia, Serratia, and Kluyvera) or 3 (Pantoea) isolates that were sensitive to florfenicol, the other 7 genera tested exhibited some degree of resistance to florfenicol. In particular, this is the first report of resistance to florfenicol among isolates of Shigella (1/2), Klebsiella (6/8), Proteus (8/9), Citrobacter (5/5), Enterobacter (2/10), and Leclercia (1/1) isolated from animals.
3.2. Distribution of Florfenicol Resistance Genes among Animal Enterobacteriaceae Isolates
Seven florfenicol resistance genes (floR, fexA, fexB, pexA, cfr, optrA, and estDL136) have been identified among bacteria. Our PCR screening of florfenicol resistance genes among 292 Enterobacteriaceae isolates revealed positive results for only floR and cfr. Among the strains, 64.4% (188/292) were positive for floR, whereas cfr was only identified in three Proteus strains (1.0%, 3/292) isolated from geese. No isolates were positive for pexA, fexA, fexB, optrA, or estDL136 (Table 3). With the exception of Enterobacter isolates exhibiting a low rate of positivity for the floR gene (30.0%), the other genera showed high floR-positive rates of 50.0-88.9%, in accordance with the florfenicol resistance rates within each genus. Proteus spp. exhibited the highest rates of resistance gene positivity, at 88.9% (8/9) for floR and 33.3% (3/9) for both floR and cfr. Of the seven florfenicol resistance genes, floR is the main and most common florfenicol resistance gene identified in both gram-positive and gram-negative bacteria  and the only one identified in K. pneumoniae strains originating from both humans and animals [11, 26]. In our study, the rate of floR positivity for K. pneumonia was 75.0% (6/8), much higher than the 7.0% (23/328) of human clinical K. pneumonia isolated from the same district  and indicating the wide use of florfenicol in local animal farming.
The rates of floR gene positivity from various bacteria differed significantly. A high rate of floR gene positivity (81.3%) has been reported for clinical Vibrio cholerae isolates from some Iranian provinces . Regarding Salmonella isolates from broiler farms in East China, the overall rate of floR gene positivity was 43.5%, and it is interesting that the rates between serotypes differed greatly. Salmonella enterica serovar Indiana isolates displayed a positive rate up to 96.2% (128/133), though that of S. enterica serovar Enteritidis strains was only 3.9% (7/177) . Among gram-negative bacteria, the cfr genes have been found in P. vulgaris (as in this work) and in E. coli [6, 14]. Moreover, floRv and floSt, variants of floR, have only been identified in a few gram-negative bacteria, including Stenotrophomonas maltophilia  and Salmonella , respectively. In contrast, estDL136 has only been identified in E. coli . fexA, fexB, pexA, optrA, and cfr were mainly harbored by gram-positive bacteria [4, 5, 28], though fexA and pexA have been found in E. coli .
3.3. Sequencing Analysis of the L. adecarboxylata R25 Genome
The floR gene has been found on the chromosome as well as plasmids. It was first identified on the chromosome of Salmonella typhimurium DT104  and later on a plasmid of E. coli isolate BN10660  and IncC plasmid R55 of K. pneumoniae , among others. However, no publication has reported the resistance level or the resistance mechanism of L. adecarboxylata to florfenicol. Thus, to elucidate the florfenicol resistance mechanism of L. adecarboxylata, we sequenced an L. adecarboxylata isolate designated as R25 isolated from rabbit feces with high MICs to florfenicol (128 μg/mL) and chloramphenicol (128 μg/mL) (Table 4). Although three complete genomes of the same species of L. adecarboxylata are available in the NCBI nucleotide database, no floR gene was identified among them. Of these three L. adecarboxylata isolates, only one, USDA-ARS-USMARC-60222 (CP013990.1), without a plasmid was from an animal (calf). The other two, LSNIH3 (CP026387.1) and LSNIH1 (CP026167.1), were from the hospital environment of housekeeping closet drains in the United States.
Abbreviations: FFC: florfenicol; CHL: chloramphenicol; RIF: rifampin; AMK: amikacin; GEN: gentamicin; STR: streptomycin; SPE: spectinomycin; KAN: kanamycin; NEO: neomycin; NAL: nalidixic acid; NOR: norfloxacin; CIP: ciprofloxacin.
The genome of L. adecarboxylata R25 consists of a 4.74 Mb circular chromosome encoding 4,293 open reading frames (ORFs) and two plasmids, pLA-64 (64,226 bp) and pLA-109 (108,995 bp) encoding 82 and 121 ORFs, respectively (Figures 1(a) and 1(b) and Table 5). Comparative genomic analysis showed that the genomes of the three L. adecarboxylata strains (USDA-ARS-USMARC-60222, CP013990.1; LSNIH3, CP026387.1; and LSNIH1, CP026167.1) share the highest chromosome sequence identities with that of L. adecarboxylata R25, at 82%, 81%, and 81% coverage and 94%, 93%, and 92% identity, respectively.
Annotation of the complete genome of L. adecarboxylata R25 revealed that it encodes nine drug resistance genes, conferring resistance to chloramphenicols (floR and mdfA), aminoglycosides (aac(6)-Ib-cr and aadA16), quinolones (qnrB6), sulfonamides (sul1), trimethoprim (dfrA27), rifampicin (arr-3), and a quaternary ammonium compound (qacEΔ1). Five resistance genes (floR, aac(6)-Ib-cr, arr-3, aadA16, and qnrB6) with their promoter regions in L. adecarboxylata R25 were cloned, and expression of these resistance genes conferred resistance to the corresponding antibiotics in comparison with the MIC levels of the control strain DH5α. Expression of the floR gene resulted in a 3-fold increase in resistance to florfenicol, with the aac(6)-Ib-cr and aadA16 genes conferring at least 3- to 6-fold increase in resistance to amikacin, kanamycin, streptomycin, and spectinomycin. For the qnrB6 gene expression, at least a 2-fold increase in resistance to nalidixic acid, norfloxacin, and ciprofloxacin was achieved and a 4-fold increase in resistance to rifampin was obtained with arr-3 (Table 4). The resistance gene profile and MIC results for the cloned resistance genes against florfenicol, chloramphenicol, rifampin, and spectinomycin were in accordance with the host’s resistance phenotypes (Table 4). A few publications have demonstrated that in nonclinical L. adecarboxylata isolates, several resistance genes (such as rmtB, qnrA, Oqxb, and qep) mediate resistance to certain antibiotics, including aminoglycosides and fluoroquinolone [17, 31]. Resistance to beta-lactams among clinical L. adecarboxylata isolates can be ascribed to the acquisition of resistance plasmids carrying blaSHV-12 and blaNDM-1 , but these isolates are generally sensitive to commonly used antibiotics such as tetracyclines, aminoglycosides, quinolones, and chloramphenicol . The floR, aadA16, and qnrB6 genes identified in L. adecarboxylata R25 have not been reported previously.
3.4. Comparative Analysis of the Resistance Plasmid pLA-64 and Resistance Gene-Related Sequences
Among 9 resistance genes, only 1 (mdfA) is located on the chromosome, whereas the other 8 (floR, aac(6)-Ib-cr, arr-3, dfrA27, aadA16, qacEΔ1, sul1, and qnrB6) are encoded by the plasmid pLA-64 (Figure 1(a)). In addition to drug resistance genes, the complete sequence encodes four clusters of heavy metal resistance genes, with one mercury resistance gene cluster on pLA-64 (Figure 1(a)) and the other three (copper, copper/silver, and arsenate resistance gene clusters) on plasmid pLA-109 (Figure 1(b)).
The sequences sharing the greatest similarities to pLA-64 are the three plasmids p02085-tetA (MH477637.1) of C. freundii strain 1509-02085 (no original information) and p234 (CP021163.1) and p388 (CP021168.1) from E. cloacae strains isolated from humans. These plasmids encompass nearly the entire sequence of pLA-64, with more than 99% coverage and 99% identity. p02085-tetA is 68 kb in length and p234 69 kb, only 4 and 5 kb longer than pLA-64, respectively, with an extra resistance gene-related fragment (encoding tetR-tetD-frmA-frmB-IS26) inserted at position 37 kb of pLA-64. p388 is 79 kb in size and 15 kb longer than pLA-64, with two extra resistance gene-related fragments inserted at positions 37 kb and 51 kb of pLA-64, respectively. The plasmid with low similarity to pLA-64 is plasmid1 (CP009116.1) from a human clinical K. pneumoniae strain; it is 95 kb in length (31 kb longer than pLA-64) and contains 81% (52/64) of the sequence of pLA-64 but without the floR gene-related region (encoding IS6-ΔIS91-virD2-floR-ΔlysR) (Figure 2). All these plasmids belong to the same Inc group carrying two replicons: FIA(HI1) and R. However, no plasmids from the two Leclercia strains LSNIH3 (CP026387.1) and LSNIH1 (CP026167.1) share sequence identity of more than 28% with pLA-64. The plasmids in these two strains harbor the replicons of other Inc groups, including N, FII (pCTU2), HI1A (CIT), and HI1B (CIT), as opposed to the FIA (HI1) and R of pLA-64. These findings indicate that pLA-64 homologous plasmids may transfer among bacteria of different genera of various (animal and human) origins.
The plasmid pLA-64 consists roughly of two parts: a backbone and a variable region. The backbone is composed of segments responsible for replication (repBE), DNA repair (umuCD), and plasmid maintenance (parAB), whereas the variable regions harbor a number of MGEs, such as insertion sequences, transposons, and an integron. All eight resistance genes encoded by the pLA-64 are related to MGEs. Six are found in a class 1 integron (intl1-aac(6)-Ib-cr-arr-3-dfrA27-aadA16-qacEΔ1-sul1); the other two (qnrB6 and floR) are related to transposons. The floR gene is located in a fragment approximately 7.6 kb in length encoding the Tn3-IS6-ΔIS91-virD2-floR-ΔlysR gene cluster (Figures 1(a) and 2). In addition to the plasmids (p02085-tetA, p234, p388, and plasmid1) mentioned above, sequences with higher identities with resistance gene-related MGEs were identified in other plasmid or chromosome sequences, such as those encoded by the chromosome of Proteus mirabilis strain PmSC1111 (CP034090.1), the chromosome of E. coli O157:H16 Santai (CP007592.1), Salmonella sp. plasmid pSa76-CIP (MG874044.1), and plasmid unnamed3 of K. pneumoniae FDAARGOS_447 (CP023950.1) (Figure 2). The gene array of the class 1 integron has also been identified in other animal bacteria of different species, such as E. coli and Enterobacter amnigenus isolated from swine feces and swine farm wastewater, respectively . Similarly, the qnrB6-related gene cluster was identified on K. pneumoniae plasmid pLC24 isolated from dog vomit . Although the genetic environment of the floR gene encoded on the chromosome or plasmid from different bacteria differed, the gene cluster of virD2-floR-ΔlysR encoded on pLA-64 in this work is conserved in most cases .
The results of this work show high rates of resistance to florfenicol (61.6%, 180/292) and chloramphenicol (65.1%, 190/292) among animal Enterobacteriaceae isolates. The floR gene is common among various species (64.4%. 188/292), though cfr was only identified in some Proteus spp. (1.0%, 3/292). All resistance genes including floR encoded on the plasmid pLA-64 in L. adecarboxylata R25 are related to MGEs. Comparative genomic analysis demonstrated that the sequences sharing the greatest similarities to pLA-64 are three plasmids from C. freundii and E. cloacae strains isolated from humans. These findings indicate a high rate of florfenicol resistance among local animal bacteria, with the floR gene also being highly prevalent. Resistance plasmids may be transferred between bacteria of different species or genera and of different (animal and human) origins and cause resistance dissemination.
4.1. Accession Numbers
The complete nucleotide sequences of the chromosome and plasmids have been submitted to the NCBI database, and the accession numbers of chromosome, pLA-64, and pLA-109 are CP035382.1, CP035381.1, and CP035380.1, respectively.
The data used to support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors declare no conflict of interest.
Yuanyuan Ying and Fei Wu contributed equally to this work.
This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LY19C060002 and LQ17H190001), the Soft Science Project of the Lishui Science and Technology Bureau (2017RKX14), the National Natural Science Foundation of China (81401702, 81501808, and 81501780), and the Science & Technology Project of the Inner Mongolia Autonomous Region, China (201802125).
Table S1: distribution of Enterobacteriaceae isolated from the animal feces specimens from the animal farms in South China. (Supplementary Materials)
- I. Chantziaras, F. Boyen, B. Callens, and J. Dewulf, “Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries,” The Journal of Antimicrobial Chemotherapy, vol. 69, no. 3, pp. 827–834, 2014.
- A. de Jong, V. Thomas, S. Simjee et al., “Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study,” Veterinary Microbiology, vol. 172, no. 1-2, pp. 202–215, 2014.
- S. Schwarz, C. Kehrenberg, B. Doublet, and A. Cloeckaert, “Molecular basis of bacterial resistance to chloramphenicol and florfenicol,” FEMS Microbiology Reviews, vol. 28, no. 5, pp. 519–542, 2004.
- H. Liu, Y. Wang, C. Wu et al., “A novel phenicol exporter gene, fexB, found in enterococci of animal origin,” The Journal of Antimicrobial Chemotherapy, vol. 67, no. 2, pp. 322–325, 2012.
- Y. Wang, Y. Lv, J. Cai et al., “A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin,” The Journal of Antimicrobial Chemotherapy, vol. 70, no. 8, pp. 2182–2190, 2015.
- A. Zhang, Y. Yang, H. Wang et al., “Prevalence of sulfonamide and florfenicol resistance genes in Escherichia Coli isolated from yaks (Bos Grunniens) and herdsmen in the Tibetan pasture,” Journal of Wildlife Diseases, vol. 51, no. 3, pp. 626–633, 2015.
- A. Alessiani, L. Sacchini, E. Pontieri, J. Gavini, and E. Di Giannatale, “Molecular typing of Salmonella enterica subspecies enterica serovar Typhimurium isolated in Abruzzo region (Italy) from 2008 to 2010,” Veterinaria Italiana, vol. 50, no. 1, pp. 31–39, 2014.
- T. He, J. Shen, S. Schwarz, C. Wu, and Y. Wang, “Characterization of a genomic island in Stenotrophomonas maltophilia that carries a novel floR gene variant,” The Journal of Antimicrobial Chemotherapy, vol. 70, no. 4, pp. 1031–1036, 2015.
- Y. Tang, L. Dai, O. Sahin, Z. Wu, M. Liu, and Q. Zhang, “Emergence of a plasmid-borne multidrug resistance gene cfr(C) in foodborne pathogen Campylobacter,” The Journal of Antimicrobial Chemotherapy, vol. 72, no. 6, pp. 1581–1588, 2017.
- S. K. Chang, D. Y. Lo, H. W. Wei, and H. C. Kuo, “Antimicrobial resistance of Escherichia coli isolates from canine urinary tract infections,” Journal of Veterinary Medical Science, vol. 77, no. 1, pp. 59–65, 2015.
- J. Lu, J. Zhang, L. Xu et al., “Spread of the florfenicol resistance floR gene among clinical Klebsiella pneumoniae isolates in China,” Antimicrobial Resistance & Infection Control, vol. 7, no. 1, p. 127, 2018.
- Y. Lu, H. Zhao, J. Sun et al., “Characterization of multidrug-resistant Salmonella enterica serovars Indiana and Enteritidis from chickens in Eastern China,” PLoS One, vol. 9, no. 5, article e96050, 2014.
- A. von Altrock, U. Roesler, R. Merle, and K. H. Waldmann, “Prevalence of pathogenic Yersinia enterocolitica strains on liver surfaces of pigs and their antimicrobial susceptibility,” Journal of Food Protection, vol. 73, no. 9, pp. 1680–1683, 2010.
- Y. Wang, Y. Wang, C. M. Wu et al., “Detection of the staphylococcal multiresistance gene cfr in Proteus vulgaris of food animal origin,” The Journal of Antimicrobial Chemotherapy, vol. 66, no. 11, pp. 2521–2526, 2011.
- H. Leclerc, “Biochemical study of pigmented Enterobacteriaceae,” Annales de l'Institut Pasteur, vol. 102, pp. 726–741, 1962.
- K. Tamura, R. Sakazaki, Y. Kosako, and E. Yoshizaki, “Leclercia adecarboxylata Gen. Nov., Comb. Nov., formerly known as Escherichia adecarboxylata,” Current Microbiology, vol. 13, no. 4, pp. 179–184, 1986.
- Q. Yao, Z. Zeng, J. Hou et al., “Dissemination of the rmtB gene carried on IncF and IncN plasmids among Enterobacteriaceae in a pig farm and its environment,” The Journal of Antimicrobial Chemotherapy, vol. 66, no. 11, pp. 2475–2479, 2011.
- A. De Mauri, D. Chiarinotti, S. Andreoni, G. L. Molinari, N. Conti, and M. De Leo, “Leclercia adecarboxylata and catheter-related bacteraemia: review of the literature and outcome with regard to catheters and patients,” Journal of Medical Microbiology, vol. 62, Part_10, pp. 1620–1623, 2013.
- S. Koren, B. P. Walenz, K. Berlin, J. R. Miller, N. H. Bergman, and A. M. Phillippy, “Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation,” Genome Research, vol. 27, no. 5, pp. 722–736, 2017.
- A. Petkau, M. Stuart-Edwards, P. Stothard, and G. Van Domselaar, “Interactive microbial genome visualization with GView,” Bioinformatics, vol. 26, no. 24, pp. 3125-3126, 2010.
- C. Kehrenberg, J. Mumme, J. Wallmann et al., “Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003,” The Journal of Antimicrobial Chemotherapy, vol. 54, no. 2, pp. 572–574, 2004.
- D. A. E. Dayao, J. S. Gibson, P. J. Blackall, and C. Turni, “Antimicrobial resistance in bacteria associated with porcine respiratory disease in Australia,” Veterinary Microbiology, vol. 171, no. 1-2, pp. 232–235, 2014.
- Y. Zhu, H. Lai, L. Zou et al., “Antimicrobial resistance and resistance genes in Salmonella strains isolated from broiler chickens along the slaughtering process in China,” International Journal of Food Microbiology, vol. 259, pp. 43–51, 2017.
- M. G. Maaland, S. S. Mo, S. Schwarz, and L. Guardabassi, “In vitro assessment of chloramphenicol and florfenicol as second-line antimicrobial agents in dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 38, no. 5, pp. 443–450, 2015.
- M. Ture, I. Altinok, and H. Alp, “Effects of cage farming on antimicrobial and heavy metal resistance of Escherichia coli, Enterococcus faecium, and Lactococcus garvieae,” Microbial Drug Resistance, vol. 24, no. 9, pp. 1422–1430, 2018.
- A. Cloeckaert, S. Baucheron, and E. Chaslus-Dancla, “Nonenzymatic chloramphenicol resistance mediated by IncC plasmid R55 is encoded by a floR gene variant,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 8, pp. 2381-2382, 2001.
- F. Rahmani, A. Fooladi, S. Marashi, and M. Nourani, “Drug resistance in Vibrio cholerae strains isolated from clinical specimens,” Acta Microbiologica et Immunologica Hungarica, vol. 59, no. 1, pp. 77–84, 2012.
- Y. Wang, W. Zhang, J. Wang et al., “Distribution of the multidrug resistance gene cfr in Staphylococcus species isolates from swine farms in China,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 3, pp. 1485–1490, 2012.
- M. A. Arcangioli, S. Leroy-Sétrin, J. L. Martel, and E. Chaslus-Dancla, “A new chloramphenicol and florfenicol resistance gene flanked by two integron structures in Salmonella typhimurium DT104,” FEMS Microbiology Letters, vol. 174, no. 2, pp. 327–332, 1999.
- A. Cloeckaert, S. Baucheron, G. Flaujac et al., “Plasmid-mediated florfenicol resistance encoded by the floR gene in Escherichia coli isolated from cattle,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 10, pp. 2858–2860, 2000.
- O. R. Akinbami, S. Olofinsae, and F. A. Ayeni, “Prevalence of extended spectrum beta lactamase and plasmid mediated quinolone resistant genes in strains of Klebsiella pneumonia, Morganella morganii, Leclercia adecarboxylata and Citrobacter freundii isolated from poultry in South Western Nigeria,” PeerJ, vol. 6, article e5053, 2018.
- F. Sun, Z. Yin, J. Feng et al., “Production of plasmid-encoding NDM-1 in clinical Raoultella ornithinolytica and Leclercia adecarboxylata from China,” Frontiers in Microbiology, vol. 6, p. 458, 2015.
- I. Stock, S. Burak, and B. Wiedemann, “Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains,” Clinical Microbiology and Infection, vol. 10, no. 8, pp. 724–733, 2004.
- Z. Liu, Z. Zhang, H. Yan, J. Li, and L. Shi, “Isolation and molecular characterization of multidrug-resistant Enterobacteriaceae strains from pork and environmental samples in Xiamen, China,” Journal of Food Protection, vol. 78, no. 1, pp. 78–88, 2015.
- J. Ma, Z. Zeng, Z. Chen et al., “High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6)-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 2, pp. 519–524, 2009.
Copyright © 2019 Yuanyuan Ying et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.